The objective of the present study mandate is to study the effect of beta-glucans to mild inflammation and saturation in cats. Inflammation or inflammation occurs in a large number of acute and chronic disorders in humans and animals and is characterized by redness, swelling, pain and heat. This inflammatory response is part of the normal antigen nonspecific immune response, but when it occurs in an uncontrolled manner will result from this disease. It also appears that in most obese patients, obesity is associated with a mild degree of inflammation, which results in a chronic activation of the antigen-nonspecific immune system and may lead to obesity-associated conditions such as insulin resistance, joint problems, mouth-disease, skin problems, disorders, of the lower urinary tract, and cardiovascular diseases. These different degrees of inflammation are in humans, but also for our pets, the cat and the dog, increasingly common.